Skip to content

Clinical trials

Phase 1/2 Gastrointestinal Stromal Tumors trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Phase: Phase 1/2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20101
20131
20152
20161
20171
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Deciphera Pharmaceuticals, LLC2
Northwestern University2
Cogent Biosciences, Inc.1
Daiichi Sankyo1
Esperas Pharma Inc.1
FeRx1
Memorial Sloan Kettering Cancer Center1
Mundipharma Research Limited1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors13
Sarcoma5
Colorectal Neoplasms4
Stomach Neoplasms4
Breast Neoplasms3
Colonic Neoplasms3
Neoplasm Metastasis3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Constipation2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.